TY - JOUR
T1 - Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features
AU - Rahmim, Arman
AU - Bak-Fredslund, Kirstine P.
AU - Ashrafinia, Saeed
AU - Lu, Lijun
AU - Schmidtlein, C. Ross
AU - Subramaniam, Rathan M.
AU - Morsing, Anni
AU - Keiding, Susanne
AU - Horsager, Jacob
AU - Munk, Ole L.
N1 - Funding Information:
This work was supported by the Danish Council for Independent Research (Medical Sciences, 4004-00022), the MSK Cancer Center Support Grant/Core Grant (P30 CA008748), and the National Natural Science Foundation of China under grants 61628105. We also acknowledge very helpful discussions with Dr. Ciprian Crainiceanu.
Funding Information:
This work was supported by the Danish Council for Independent Research (Medical Sciences, 4004-00022 ), the MSK Cancer Center Support Grant/Core Grant ( P30 CA008748 ), and the National Natural Science Foundation of China under grants 61628105 . We also acknowledge very helpful discussions with Dr. Ciprian Crainiceanu.
Funding Information:
Dr. Lu: National Natural Science Foundation of China. No disclosures exist for any other authors.
Publisher Copyright:
© 2019 Elsevier B.V.
PY - 2019/4
Y1 - 2019/4
N2 - Objective: We aimed to improve prediction of outcome for patients with colorectal liver metastases, via prognostic models incorporating PET-derived measures, including radiomic features that move beyond conventional standard uptake value (SUV) measures. Patients and methods: A range of parameters including volumetric and heterogeneity measures were derived from FDG PET images of 52 patients with colorectal intrahepatic-only metastases (29 males and 23 females; mean age 62.9 years [SD 9.8; range 32–82]). The patients underwent PET/CT imaging as part of the clinical workup prior to final decision on treatment. Univariate and multivariate models were implemented, which included statistical considerations (to discourage false discovery and overfitting), to predict overall survival (OS), progression-free survival (PFS) and event-free survival (EFS). Kaplan-Meier survival analyses were performed, where the subjects were divided into high-risk and low-risk groups, from which the hazard ratios (HR) were computed via Cox proportional hazards regression. Results: Commonly-invoked SUV metrics performed relatively poorly for different prediction tasks (SUVmax HR = 1.48, 0.83 and 1.16; SUVpeak HR = 2.05, 1.93, and 1.64, for OS, PFS and EFS, respectively). By contrast, the number of liver metastases and metabolic tumor volume (MTV) each performed well (with respective HR values of 2.71, 2.61 and 2.42, and 2.62, 1.96 and 2.29, for OS, PFS and EFS). Total lesion glycolysis (TLG) also resulted in similar performance as MTV. Multivariate prognostic modeling incorporating different features (including those quantifying intra-tumor heterogeneity) resulted in further enhanced prediction. Specifically, HR values of 4.29, 4.02 and 3.20 (p-values = 0.00004, 0.0019 and 0.0002) were obtained for OS, PFS and EFS, respectively. Conclusions: PET-derived measures beyond commonly invoked SUV parameters hold significant potential towards improved prediction of clinical outcome in patients with liver metastases, especially when utilizing multivariate models.
AB - Objective: We aimed to improve prediction of outcome for patients with colorectal liver metastases, via prognostic models incorporating PET-derived measures, including radiomic features that move beyond conventional standard uptake value (SUV) measures. Patients and methods: A range of parameters including volumetric and heterogeneity measures were derived from FDG PET images of 52 patients with colorectal intrahepatic-only metastases (29 males and 23 females; mean age 62.9 years [SD 9.8; range 32–82]). The patients underwent PET/CT imaging as part of the clinical workup prior to final decision on treatment. Univariate and multivariate models were implemented, which included statistical considerations (to discourage false discovery and overfitting), to predict overall survival (OS), progression-free survival (PFS) and event-free survival (EFS). Kaplan-Meier survival analyses were performed, where the subjects were divided into high-risk and low-risk groups, from which the hazard ratios (HR) were computed via Cox proportional hazards regression. Results: Commonly-invoked SUV metrics performed relatively poorly for different prediction tasks (SUVmax HR = 1.48, 0.83 and 1.16; SUVpeak HR = 2.05, 1.93, and 1.64, for OS, PFS and EFS, respectively). By contrast, the number of liver metastases and metabolic tumor volume (MTV) each performed well (with respective HR values of 2.71, 2.61 and 2.42, and 2.62, 1.96 and 2.29, for OS, PFS and EFS). Total lesion glycolysis (TLG) also resulted in similar performance as MTV. Multivariate prognostic modeling incorporating different features (including those quantifying intra-tumor heterogeneity) resulted in further enhanced prediction. Specifically, HR values of 4.29, 4.02 and 3.20 (p-values = 0.00004, 0.0019 and 0.0002) were obtained for OS, PFS and EFS, respectively. Conclusions: PET-derived measures beyond commonly invoked SUV parameters hold significant potential towards improved prediction of clinical outcome in patients with liver metastases, especially when utilizing multivariate models.
KW - Colorectal liver metastasis
KW - Intra-tumoral heterogeneity
KW - PET/CT
KW - Prognosis
KW - Radiomics
KW - Volumetric features
UR - http://www.scopus.com/inward/record.url?scp=85061554275&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061554275&partnerID=8YFLogxK
U2 - 10.1016/j.ejrad.2019.02.006
DO - 10.1016/j.ejrad.2019.02.006
M3 - Article
C2 - 30927933
AN - SCOPUS:85061554275
SN - 0720-048X
VL - 113
SP - 101
EP - 109
JO - European Journal of Radiology
JF - European Journal of Radiology
ER -